In-silico screening and molecular docking studies of active constituents of Withania somnifera to investigate its kinase inhibitory activities. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, n. 4, p. 1342–1349, 2022. DOI: 10.47750/pnr.2022.13.04.187. Disponível em: https://pnrjournal.com/index.php/home/article/view/3772.. Acesso em: 5 jun. 2026.